Wellington Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$838K Sell
7,370
-192
-3% -$21.8K ﹤0.01% 1735
2025
Q1
$795K Sell
7,562
-41
-0.5% -$4.31K ﹤0.01% 1751
2024
Q4
$815K Sell
7,603
-1,085
-12% -$116K ﹤0.01% 1736
2024
Q3
$870K Sell
8,688
-5,714
-40% -$572K ﹤0.01% 1723
2024
Q2
$1.21M Buy
14,402
+1,854
+15% +$156K ﹤0.01% 1624
2024
Q1
$917K Sell
12,548
-2,139
-15% -$156K ﹤0.01% 1701
2023
Q4
$1.05M Buy
+14,687
New +$1.05M ﹤0.01% 1617
2020
Q1
Sell
-268,387
Closed -$17.5M 1992
2019
Q4
$17.5M Sell
268,387
-7,044
-3% -$458K ﹤0.01% 1023
2019
Q3
$17.1M Sell
275,431
-10,414
-4% -$647K ﹤0.01% 1010
2019
Q2
$20.4M Buy
285,845
+10,462
+4% +$745K ﹤0.01% 1004
2019
Q1
$21.6M Buy
+275,383
New +$21.6M ﹤0.01% 996
2018
Q3
Sell
-6,803
Closed -$879K 2271
2018
Q2
$879K Sell
6,803
-1,148
-14% -$148K ﹤0.01% 1919
2018
Q1
$819K Buy
7,951
+66
+0.8% +$6.8K ﹤0.01% 1932
2017
Q4
$674K Hold
7,885
﹤0.01% 1959
2017
Q3
$670K Hold
7,885
﹤0.01% 1948
2017
Q2
$597K Buy
+7,885
New +$597K ﹤0.01% 1982
2016
Q1
Sell
-31,332
Closed -$2.12M 2157
2015
Q4
$2.12M Sell
31,332
-8,773
-22% -$593K ﹤0.01% 1604
2015
Q3
$2.14M Buy
40,105
+19,665
+96% +$1.05M ﹤0.01% 1611
2015
Q2
$1.29M Sell
20,440
-28,484
-58% -$1.79M ﹤0.01% 1780
2015
Q1
$2.35M Sell
48,924
-9,778
-17% -$470K ﹤0.01% 1642
2014
Q4
$1.95M Sell
58,702
-4,328
-7% -$144K ﹤0.01% 1693
2014
Q3
$1.85M Buy
63,030
+21,810
+53% +$639K ﹤0.01% 1695
2014
Q2
$1.6M Buy
41,220
+953
+2% +$37K ﹤0.01% 1718
2014
Q1
$1.69M Sell
40,267
-309,564
-88% -$13M ﹤0.01% 1726
2013
Q4
$11.5M Sell
349,831
-476,091
-58% -$15.6M ﹤0.01% 1194
2013
Q3
$22.3M Sell
825,922
-140,102
-15% -$3.78M 0.01% 954
2013
Q2
$22.6M Buy
+966,024
New +$22.6M 0.01% 936